Terms: = Pancreatic cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Staging
3 results:
1. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
2. A non-surgical COMBO-therapy approach for locally advanced unresectable pancreatic adenocarcinoma: preliminary results of a prospective study.
Parisi S; Ferini G; Cacciola A; Lillo S; Tamburella C; Santacaterina A; Bottari A; Brogna A; Ferrantelli G; Pontoriero A; Minutoli F; Pergolizzi S
Radiol Med; 2022 Feb; 127(2):214-219. PubMed ID: 35034325
[TBL] [Abstract] [Full Text] [Related]
3. Keratin-17 Promotes p27kip1 Nuclear Export and Degradation and Offers Potential Prognostic Utility.
Escobar-Hoyos LF; Shah R; Roa-Peña L; Vanner EA; Najafian N; Banach A; Nielsen E; Al-Khalil R; Akalin A; Talmage D; Shroyer KR
Cancer Res; 2015 Sep; 75(17):3650-62. PubMed ID: 26109559
[TBL] [Abstract] [Full Text] [Related]
